We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
An SI Board Since March 1998
Posts SubjectMarks Bans Symbol
53 4 0 CZO
Emcee:  fivedollar Type:  Unmoderated
The latest news release regarding $10 million financing, debt restructuring and bank support should have a very positive impact, near term.

Successful completion of the financing and majority approval from creditors appears to be iminent. This clearly enables the company to move forward as a clean balance sheet and sufficient working captial will prove to be the ingredients for future success.

Sales forcasts of $14 million for 1998 appear to be on line and may even prove to be low as commercialization of the "Diabetes screening product" may be closer at hand than originally expected.

In the absence of any surprises such as the "DSP", the companies other products are gaining significant world wide acceptance. Efficacy data continues to prove the benefits of Ceapro's products and the list of country distributors continues to grow with a Korean distributor just having been appointed.

It is my opinion that many in the investment industry, including analysts, have not taken the time to understand what this company is all about. I have personally taken the time to learn the benefits of their products and am quite excited to find that the size of their market is very significant . I have sampled a couple of Ceapro's products and have no doubt that this is a company of the future with huge potential.

Although final approval on the restructuring is not until March 25, I am very confident that the vote will be a formality. The past year has been quite disappointing for many who follow Ceapro Inc, however, it appears that the company may have reached a turning point. For those who have been patient and those who have sought opportunity at these levels, some rewarding may be near.
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
53The BG study did not have positive results to allow them to move forward. Howeveciao888-August 12
52Ceapro AGM They are very positive on their BG pill study with results due by yeciao888-5/31/2021
51EDMONTON, Alberta, Oct. 22, 2020 (GLOBE NEWSWIRE) -- Ceapro Inc. ( TSX-V: CZO ;ciao888-10/23/2020
50Mike, I don't believe I asked you to move on from Ceapro. But if that workeciao888-9/29/2020
49Thank you Ciao888 for the advice to move on from Ceapro , The Saturday after thmikefrmcanmore-9/29/2020
48Correction, the years should read 2020, not 2019.ciao888-8/31/2020
47He had projected 2019 revenues. I did the H2 analysis against his 2019 revenue aciao88818/27/2020
46Checking Dr. Cosme Ordonez' Linkedin Page, He left Noble Life Sciences in Mmikefrmcanmore-8/27/2020
45Thank You for the reply . Up above , on this Silicon Investor site. In 1998, Cemikefrmcanmore-8/27/2020
44The analyst Cosme Ordonez, MD, Ph.D., is no longer with Noble, having just left ciao888-8/27/2020
43HI , Would You have a name for the Noble Analyst? I can't locate anything mikefrmcanmore-8/27/2020
42The Noble analyst had 2020 year rev at $13.4M, R&D at $2.7M and net income aciao888-8/27/2020
41I don't think you are able to delete messages on SH. If you read further yociao888-8/24/2020
40Thank You for the Welcome , I have been trying to do some DD on this Ceapro . mikefrmcanmore-8/24/2020
39Mike, Welcome to this "quiet" thread. You can find lots of info fromciao888-8/24/2020
38Ceapro looks very interesting . Doing some Internet searches, it was really homikefrmcanmore-8/21/2020
37CZO Q2 results in summary: – Record second quarter sales of $4,666,000 comparedciao888-8/21/2020
36EDMONTON, Alberta, Aug. 04, 2020 (GLOBE NEWSWIRE) -- Ceapro Inc.(TSX-V: CZO; OTciao888-8/4/2020
35ciao888 You are correct, this is a very non-promotional company. I think that haroldhecubah-7/25/2020
34Hi Harold, It's too bad that Ceapro remains non-promotional and goes about ciao888-7/23/2020
33ciao888 Looking good again today with no selling volume to speak of. With thisharoldhecubah-7/20/2020
32Interesting share price action today - relatively high volume of about 250K witciao888-7/16/2020
31Things appear be be finally turning around now. 3 major catalysts for Ceapro inciao888-6/20/2020
30Ceapro (CZO) This stock was hyped on BNN in early to mid 2016 which took it to ciao888-11/8/2018
29Anyone still here? Or have you all moved to Stockhouse?ciao888-3/26/2016
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):